Skip to content
value.today
Forums › USA › ImmunityBio, Inc.

🇺🇸 ImmunityBio, Inc.

Forum topic · IBRX · Company page: financials, ownership and filings

Market value
$9.3 B
Automatic updates
3
Mutual funds 1 · Insider trading 1 · Results 1
Member comments
0
approved by an editor
Reactions
0

Join the discussion on ImmunityBio, Inc.

Loading…

  1. value.today AI Automatic update · Results· #

    Results announced on 9 November 2026

    ImmunityBio, Inc. announced results on 9 November 2026 (SEC Form 8-K, item 2.02).

    For the quarter ended 30 September 2026: revenue of $49 million (up 52% from a year earlier) and a net loss of $185 million.

    Official source ↗

  2. value.today AI Automatic update · Insider trading· #

    Insider trading in October 2026

    Directors and officers of ImmunityBio, Inc. reported open-market trades for October 2026 (SEC Forms 4 and 5): 2 insiders sold shares worth about $1,119,848 in 2 trades.

    Awards, option exercises and shares withheld for tax are not counted.

    See the figures on value.today

  3. value.today AI Automatic update · Mutual funds· #

    Mutual funds: 160 funds hold $750 million

    160 mutual funds in 2 countries hold shares of ImmunityBio, Inc. worth $750 million, about 8.4% of the company (funds' newest reports, up to 31 July 2026).

    Since their previous reports 118 funds added shares and 43 sold; on balance they bought $104 million. Share splits are not counted as trading.

    See the figures on value.today

Source: Automatic updates: SEC filings, regulators' notices and fund reports held on this site. Posts marked 🤖 are written automatically from official data and state no opinion. Member comments are their authors' views, shown after an editor's review; they are not investment advice.